Ignite Creation Date:
2025-12-24 @ 11:25 PM
Ignite Modification Date:
2025-12-25 @ 9:10 PM
Study NCT ID:
NCT01393756
Status:
COMPLETED
Last Update Posted:
2023-12-05
First Post:
2011-07-04
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Revlimid Dose 25 mg in Association With (R-CHOP) in the Treatment Follicular Lymphoma
Sponsor:
The Lymphoma Academic Research Organisation
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-12
Start Date Type:
None
Primary Completion Date:
2013-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-11
Completion Date Type:
ACTUAL
First Submit Date:
2011-07-04
First Submit QC Date:
None
Study First Post Date:
2011-07-13
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-12-04
Last Update Post Date:
2023-12-05
Last Update Post Date Type:
ACTUAL